Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Inorg Chem ; 62(26): 10408-10419, 2023 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-37347952

RESUMO

KNbO3 (KN) with a perovskite structure is an outstanding representative of lead-free piezoelectric materials, and its mesocrystals have broad application prospects in the fields of catalysis, energy storage, and conversion. However, the formation conditions of KN mesocrystals reported so far are difficult owing to their high aspect ratio and excellent preferred orientation. In this study, the solvothermal process was used successfully to prepare the flake-like potassium salt of Lindquist hexaniobate (K8Nb6O19·10H2O). Subsequently, the precursor niobate was calcined to prepare two-dimensional (2D) plate-like KN mesocrystals. The formation mechanism of the plate-like KN mesocrystals is further revealed from a paired topochemical mesocrystal conversion of K8Nb6O19·10H2O niobate. Finally, the microscopic piezoelectric and photocatalytic responses of the obtained plate-like KN mesocrystals were investigated. The high piezoelectric coefficient of plate-like KN mesocrystals implies that excellent charge separation promotes the photocatalytic performance of rhodamine B (RhB). This study provides a strategy for the efficient application of 2D oriented materials in the field of piezoelectricity and photocatalysis.

2.
Inorg Chem ; 60(1): 97-107, 2021 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-33314906

RESUMO

KNbO3 (KN) piezoelectric polycrystals were prepared by a two-step solvothermal reaction process with the managed organic solvents as reaction mediums at a low temperature for a short time. In the solvothermal reaction system, the formation mechanism of polycrystalline KN is mainly the dissolution-deposition mechanism. The influences of alkalinity, viscosity, and the polarity for reaction mediums on the formation of the niobates were investigated. The chemical reaction mechanisms of niobate products and formation mechanism of niobate crystals from the precursor were clarified. The regulating and controlling mechanism of the phase compositions, the morphologies, and the lattice constants for the niobates obtained in varied reaction mediums were revealed. The obtained KN piezoelectric polycrystals are constructed from oriented KN nanocrystals. Piezoelectric hysteresis loops of cuboid KN polycrystals were detected for the first time. A prepared cuboid KN polycrystal shows an average d33* value of 32 pm/V. The study provides a strategy for the development of oriented KN piezoelectric materials to apply the orientation engineering.

3.
RSC Adv ; 14(15): 10298-10303, 2024 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-38549790

RESUMO

Electrochromic smart windows have attracted more attention from researchers due to their potential applications for energy conservation in buildings. As the most key component, the electrochromic layer is still limited by the complexity of the preparation process and poor performance, such as lower stability, slow response time, and low coloration efficiency. In this study, as a simple and expedient method, electrodeposition is successfully used to prepare amorphous WO3 films doped with P. By optimizing the amount of P in the PW-2 film, a large optical modulation of 80.8% at 550 nm is achieved, and the P-doped amorphous WO3 film also shows a fast response time, a high CE, and good cycling stability. The mechanism of the P-doped amorphous WO3 films to improve the electrochromic properties is as follows. Firstly, by appropriate phosphorus doping, the stress of the film is released, and the binding force is improved. Secondly, the films possess proper cracks, which accelerate the diffusion of ions. Thirdly, the films make the nanoparticles more uniform, and provide more active sites. Furthermore, the electrochromic smart windows based on the P-doped amorphous WO3 film display a large temperature difference of 11 °C, which indicates good solar thermal regulation ability, and promises practical applications for building energy conservation.

4.
Arch Virol ; 158(4): 785-91, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23183771

RESUMO

The treatment of infection with lamivudine-resistant mutants of hepatitis B virus (HBV) with mutations in the YMDD motif has become a crucial issue in the clinic. In this work, the plasmids pcDNA3.1 (+)-HBV/C-YVDD and pcDNA3.1 (+)-HBV/C-YMDD were constructed and injected into BALB/c mice using a hydrodynamics-based procedure to investigate viral replication and expression of HBV lamivudine-resistant YVDD mutants in vivo. Compared with the YMDD group, HBsAg levels were higher in sera of mice in the YVDD group, but HBeAg levels were lower on day 1 after injection. Levels of HBcAg in hepatocytes were higher in the YVDD group on day 1, whereas the HBsAg levels were lower. The levels of HBV mRNA in the liver were higher in mice in the YVDD group on day 1 after injection. The results showed that injection with these plasmids resulted in efficient initiation of replication of HBV in mice and also suggested that the combined mutations in YVDD mutants could affect the replication process.


Assuntos
Modelos Animais de Doenças , Vírus da Hepatite B/genética , Hepatite B/virologia , Hepatite Viral Animal/virologia , Animais , Ensaio de Imunoadsorção Enzimática , Feminino , Regulação Viral da Expressão Gênica/fisiologia , Antígenos de Superfície da Hepatite B/isolamento & purificação , Antígenos E da Hepatite B/isolamento & purificação , Fígado/patologia , Fígado/virologia , Camundongos , Camundongos Endogâmicos BALB C , Mutação , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , DNA Polimerase Dirigida por RNA , Organismos Livres de Patógenos Específicos
5.
Chem Commun (Camb) ; 59(40): 6060-6063, 2023 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-37114352

RESUMO

A series of Ti-doped W18O49 samples were prepared using a convenient solvothermal route. Due to the synergistic effect of doped Ti and oxygen vacancies, the samples showed excellent visible-light photochromic properties. Their performances as light-printable rewritable paper and smart windows showed great application value and promotion value.

6.
J Clin Microbiol ; 49(7): 2656-63, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21593270

RESUMO

Human papillomavirus type 16 (HPV 16) plays a cardinal role in the pathogenesis of cervical cancer. HPV 16 has intratypic variants which show different geographical distributions and different oncogenic potentials. To analyze the presence of sequence variations of HPV 16 variants in northeast China, 71 cervical carcinomas were identified by HPV typing. HPV 16-positive specimens were analyzed by PCR-directed sequencing in the E6, E7, and L1 genes and the LCR (long control region). The variation data were compared with those of neighboring districts. In this hospital-based study, HPV 16 was the most common type (73.24%). In HPV 16-positive specimens, 67.31% belonged to the European (E) lineage, while 32.69% were Asian (As) variants. The Asian-American (AA), African-1 (Af-1), African-2 (Af-2), and northern American (NA) lineages were not detected. The most frequently observed variation sites were T178G (32.69%) in E6; A647G (34.62%), G666A (38.46%), and T846C (32.69%) in E7; C6826T (36.17%) and G7060A (61.70%) in L1; and G7521A (98.08%) in the LCR. The most prevalent amino acid variations were D25E in E6 and N29S in E7. In addition, 28 novel variations of HPV 16 were reported. Some covariations between different genes were obtained. In this study, HPV 16 variants belonged to the European lineage and the Asian lineage. Compared with neighboring districts, the distribution of HPV 16 variants in northeast China had a typical pattern. As the first report on HPV 16 variants in northeast China, it should be helpful for designing a HPV vaccine and HPV vaccination program in China.


Assuntos
Proteínas do Capsídeo/genética , Carcinoma/diagnóstico , Papillomavirus Humano 16/genética , Papillomavirus Humano 16/patogenicidade , Proteínas Oncogênicas Virais/genética , Proteínas E7 de Papillomavirus/genética , Proteínas Repressoras/genética , Neoplasias do Colo do Útero/diagnóstico , Substituição de Aminoácidos/genética , Sequência de Bases , Carcinoma/virologia , China , Feminino , Papillomavirus Humano 16/classificação , Papillomavirus Humano 16/isolamento & purificação , Humanos , Dados de Sequência Molecular , Infecções por Papillomavirus/complicações , Mutação Puntual , Polimorfismo Genético , Neoplasias do Colo do Útero/virologia
7.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi ; 28(5): 988-91, 2011 Oct.
Artigo em Zh | MEDLINE | ID: mdl-22097269

RESUMO

This study was aimed to identify pET21b-HPV16E2/BL21(DE3) strain and to optimize the expression of human papillomavirus type 16 (HPV16) E2 protein by orthogonal analysis. Four influence factors on two levels were selected to increase the target protein quantity. The four factors were induction time, induction temperature, inductor concentration and cell density. The quantity of HPV16 E2 protein was used as the evaluation parameter. Induced by IPTG, HPV16 E2 protein was analyzed by SDS-PAGE and Western Blot. Target protein was analyzed by GIS imaging system to quantify the protein level. SPSS13. 0 software was applied to analyze the result. Data showed that the expression strain pET211rHPV16 E2/BL21(DE3) was identified correctly. HPV16 E2 protein expressed mainly at insoluble form. The 42KD protein band was identified by SDS-PAGE and Western blot. Orthogonal test was applied on influence factor analysis and expression optimization successfully. Main influence factors were inductor concentration and induction temperature. The optimimum condition of maximum expression quantity was 37 degrees C, 7h, 1.0 mmol/L IPTG and OD600 1.0. In this experiment, orthogonal test could not only be used to analyze the influential factors and promote the target protein expression, but also be used to provide a better experiment method for molecular biological study.


Assuntos
Proteínas de Ligação a DNA/biossíntese , Papillomavirus Humano 16/metabolismo , Proteínas Oncogênicas Virais/biossíntese , Proteínas de Ligação a DNA/genética , Vetores Genéticos/genética , Humanos , Proteínas Oncogênicas Virais/genética , Infecções por Papillomavirus/virologia , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética
8.
Anal Biochem ; 400(1): 99-102, 2010 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-20056100

RESUMO

A novel and sensitive biosensor based on aptamer and pyrene-labeled fluorescent probes for the determination of K+ was developed. The aptamer was used as a molecular recognition element and a partially complementary oligonucleotide with the aptamer was labeled by pyrene moieties at both ends to transduce the binding event of K+ with aptamer. In the presence of K+, the complementary oligonucleotides were displaced from aptamers, which was accompanied by excimer fluorescence of pyrenes because the self-hairpin structure of the complementary oligonucleotide brought pyrene moieties into close proximity. However, it gave only monomer emission in the absence of K+. Under optimum conditions, the relative fluorescence intensity of pyrene was proportional to the concentration of K+ in the range of 6.0 x 10(-4) to 2.0 x 10(-2) M. A detection limit of 4.0 x 10(-4) M was achieved. Moreover, this method was able to detect K+ with high selectivity in the presence of Na+, NH4+, Mg2+, and Ca2+ ions of biological fluids. In brief, the assay may have great potential applications, especially in a biological environment because of its simplicity, sensitivity, and specificity.


Assuntos
Aptâmeros de Nucleotídeos/química , Técnicas Biossensoriais/métodos , Corantes Fluorescentes/química , Potássio/química , Pirenos/química , Oligonucleotídeos/química , Espectrometria de Fluorescência
9.
J Med Virol ; 81(5): 826-35, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19319940

RESUMO

Occult HBV infection is defined as the persistence of HBV DNA in individuals negative for HBV surface antigen (HBsAg), and many different mechanisms have been reported in different countries. However, in China, one of the endemic areas for HBV infection, no reports have been published on occult HBV infection. The present study investigated the virological features and the mechanism of occult HBV infection in China. Full-length HBV DNA from eight patients with occult HBV infection (S1-S8) and three HBsAg-positive cases (SWT1-SWT3) was cloned and sequenced. Additionally, four entire linear HBV genomes from occult cases were transfected transiently into HepG2 cells. The sequencing results showed two major mutations in patients with occult HBV infection as follows: deletions in the pre-S1 (S3, S4, and S7) and X (S1, S2, and S5) regions. Such deletions covered the S promoter and the basal core promoter (BCP), and function analysis of these variants also showed a decrease in DNA replication and antigen expression. Two patients with occult infection (S6 and S8) had no mutations capable of interfering with viral replication and gene expression in the major viral population. Thus, the deletions in the S promoter and the BCP regions that disable the regulatory elements may be the reason for the absence of HBsAg, and multiple mechanisms may be responsible for occult HBV infection.


Assuntos
DNA Viral/sangue , Vírus da Hepatite B , Hepatite B , Idoso , Linhagem Celular , China/epidemiologia , Clonagem Molecular , DNA Viral/análise , DNA Viral/genética , DNA Viral/isolamento & purificação , Feminino , Deleção de Genes , Genótipo , Hepatite B/epidemiologia , Hepatite B/patologia , Hepatite B/virologia , Antígenos de Superfície da Hepatite B/sangue , Vírus da Hepatite B/classificação , Vírus da Hepatite B/genética , Vírus da Hepatite B/patogenicidade , Humanos , Masculino , Pessoa de Meia-Idade , Regiões Promotoras Genéticas , Análise de Sequência de DNA
10.
Virus Res ; 132(1-2): 237-41, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18178281

RESUMO

To investigate the pathogenic risk of endogenous retroviruses (ERVs) infection in immunodeficient hosts, the ERV of N-type ecotropic murine leukemia virus (MuLV) isolated from SL mice, a kind of mice containing considerable infectious ERV particles determined with SC-XC test and developing leukemia spontaneously with average of high frequency of 30% and incubation period of 315days, was inoculated intraperitoneally into newborn CBA nude mice. The distinct marker of splenomegaly for leukemia was observed in 33% of homozygous (nu/nu) and 17% of heterozygous (nu/+) of CBA nude mice with average incubation period of 310days and 432days post-inoculation, respectively. Furthermore, the ERV induced leukemia in both the SL mice and CBA nude mice was identified to be B lymphatic, transplantable and with rearrangement of the Evi-1 locus. The higher induction of leukemia and rearrangement of the Evi-1 locus in CBA nude mice are considered to be dependent on the lower immune status of the hosts. These findings indicate that the ERV could present the host immune dependent leukemogenesis in immunodeficient hosts through the Evi-1 gene rearrangement and suggest that screening of ERVs may be necessary in clinical transplantation or transfusion.


Assuntos
Retrovirus Endógenos/imunologia , Hospedeiro Imunocomprometido , Vírus da Leucemia Murina/imunologia , Infecções por Retroviridae/imunologia , Animais , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Rearranjo Gênico , Síndromes de Imunodeficiência , Vírus da Leucemia Murina/genética , Leucemia Experimental/genética , Leucemia Experimental/imunologia , Leucemia Experimental/patologia , Proteína do Locus do Complexo MDS1 e EVI1 , Camundongos , Camundongos Endogâmicos CBA , Camundongos Nus , Proto-Oncogenes/genética , Infecções por Retroviridae/genética , Infecções por Retroviridae/patologia , Risco , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo
11.
World J Gastroenterol ; 14(23): 3733-8, 2008 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-18595141

RESUMO

AIM: To construct eukaryotic expression plasmids of full-length Hepatitis B Virus (HBV) genotype C genome, which contain lamivudine-resistant mutants (YIDD, YVDD) or wild-type strain (YMDD), and to observe the expression of HBV DNA and antigens [hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg)] of the recombinant plasmids in HepG2 cells. METHODS: Three HBV full-length genomes were amplified from the plasmids pMD18T-HBV/YIDD, pMD18T-HBV/YVDD and pMD18T-HBV/YMDD, using PCR. Three recombinant plasmids were generated by inserting each of the PCR products into the eukaryotic expression vector pcDNA3.1 (+), between the EcoRI and HindIII sites. After being characterized by restriction endonuclease digestion, and DNA sequence analysis, the recombinant plasmids were transfected into HepG2 cells. At 48 and 72 h post-transfection, the levels of intracellular viral DNA replication were detected by real-time PCR, and the expression of HBsAg and HBeAg in the cell culture supernatant was determined by ELISA. RESULTS: Restriction endonuclease digestion and DNA sequence analysis confirmed that the three recombinant plasmids were correctly constructed. After transfecting the plasmids into HepG2 cells, high levels of intracellular viral DNA replication were observed, and HBsAg and HBeAg were secreted into the cell culture supernatant. CONCLUSION: Eukaryotic expression plasmids pcDNA3.1 (+)-HBV/YIDD, pcDNA3.1 (+)-HBV/YVDD or pcDNA3.1 (+)-HBV/YMDD, which contained HBV genotype C full-length genome, were successfully constructed. After transfection into HepG2 cells, the recombinant plasmids efficiently expressed HBV DNA, HBsAg and HBeAg. Our results provide an experimental basis for the further study of HBV lamivudine-resistant mutants.


Assuntos
Antivirais/farmacologia , Farmacorresistência Viral/genética , Regulação Viral da Expressão Gênica , Vetores Genéticos , Vírus da Hepatite B/genética , Lamivudina/farmacologia , Plasmídeos , Linhagem Celular Tumoral , DNA Viral/biossíntese , Genoma Viral , Genótipo , Antígenos de Superfície da Hepatite B/biossíntese , Antígenos de Superfície da Hepatite B/genética , Antígenos E da Hepatite B/biossíntese , Antígenos E da Hepatite B/genética , Vírus da Hepatite B/efeitos dos fármacos , Vírus da Hepatite B/crescimento & desenvolvimento , Vírus da Hepatite B/imunologia , Humanos , Mutação , Proteínas Recombinantes/biossíntese , Análise de Sequência de DNA , Fatores de Tempo , Transfecção , Replicação Viral
12.
Hepatogastroenterology ; 55(88): 2178-83, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19260501

RESUMO

BACKGROUND/AIMS: Hepatitis B virus (HBV) infection is a world-wide health problem. The major obstacles for current anti-HBV therapy are the low efficacy and the occurrence of drug resistant HBV mutations. Recent studies have demonstrated that combination therapy can enhance antiviral efficacy and overcome the shortcomings. Here, the inhibitory effect mediated by combination of small interfering RNAs (siRNAs) targeting different sites of HBV nuclear localization signal (NLS) was monitored in HepG2.2.15 cells. METHODOLOGY: Recombinant plasmid psil-HBV was constructed and transfected into HepG2.2.15 cells. At 48, 72 and 96 h after transfection, culture media were collected and cells were harvested for HBV replication assay. HBsAg and HBeAg in the cell culture medium were detected by enzyme-linked immunoadsorbent assay. Intracellular viral DNA and covalently closed circular DNA (cccDNA) was quantified by real-time PCR. HBV viral mRNA was reverse transcribed and quantified by reverse-transcript PCR. RESULTS: Our data demonstrated that three used siRNAs showed marked anti-HBV effects. The expression of HBsAg and the replication of HBV DNA could be specifically inhibited in a dose-dependent manner by siRNAs. Furthermore, combination of siRNAs, compared with individual use of each siRNA, exerted a stronger inhibition on antigen expression and viral replication, even though the final concentration of siRNA in the therapy was the same. More importantly, we showed that combination therapy significantly suppressed HBV cccDNA amplification. CONCLUSION: Our results revealed that combination of siRNAs mediated a stronger inhibition on viral replication and antigen expression in HepG2.2.15 cells, especially, the amplification of cccDNA.


Assuntos
Carcinoma Hepatocelular/virologia , DNA Viral/efeitos dos fármacos , DNA Viral/metabolismo , Vírus da Hepatite B/genética , Neoplasias Hepáticas/virologia , RNA Interferente Pequeno/farmacologia , Replicação Viral/efeitos dos fármacos , Carcinoma Hepatocelular/imunologia , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Antígenos de Superfície da Hepatite B/metabolismo , Antígenos E da Hepatite B/metabolismo , Vírus da Hepatite B/efeitos dos fármacos , Humanos , Neoplasias Hepáticas/imunologia , Plasmídeos , Transfecção , Replicação Viral/genética
13.
J Colloid Interface Sci ; 518: 84-91, 2018 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-29448229

RESUMO

We developed a facile and efficient route to prepare highly porous nanostructure MnO2 by etching of proton-type layered manganese oxide (H-MnO2) with sulfuric acid (H2SO4). Results from TEM images and N2 adsorption showed that H2SO4 etching created porous MnO2 with average pore size of about 4 nm and high specific surface area (315 m2 g-1). With such porous structure, the obtained MnO2 exhibits a high specific capacitance of 253 F g-1 and enhanced rate capability (62.1% capacitance retention from 0.5 to 10 A g-1) when comparing with the H-MnO2 precursor (154 F g-1, 45.5%) and annealed H-MnO2 in the absence of H2SO4 (134 F g-1, 43.3%). The excellent capacitive properties demonstrate that creation of porous structure on H-MnO2 not only provides large ion-accessible surface area for efficient charge storage, but also to some extent promotes the kinetics of electrochemical reactions.

14.
ACS Nano ; 12(1): 559-567, 2018 01 23.
Artigo em Inglês | MEDLINE | ID: mdl-29294270

RESUMO

Over the past years the performance of electrochromic smart windows with the promising potential for significant energy savings has been progressively improved; however, the electrochromic windows have not yet to come into use at scale mainly because the electrochromic materials suffer from some significant drawbacks such as low coloration efficiency, slow switching time, bad durability and poor functionality. Herein, we fabricate the optically modulated electrochromic smart devices through sequential deposition of the crown-type polyoxometalates, K28Li5H7P8W48O184·92H2O (P8W48), and W18O49 nanowires. Unlike most reported electrochromic smart devices, the resulting P8W48 and W18O49 nanocomposites allow active and selective manipulation of the transmittance of near-infrared (750-1360 nm) and visible light (400-750 nm) by varying the applied potential. Furthermore, thanks to the stable nature of both P8W48 and W18O49 and precise structural control over the nanocomposites, the prepared electrochromic smart devices exhibit high efficiency, quick response and excellent stability.

15.
World J Gastroenterol ; 13(16): 2324-7, 2007 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-17511031

RESUMO

AIM: To observe the inhibition of hepatitis B virus (HBV) replication and expression by combination of siRNA and lamivudine in HepG2.2.15 cells. METHODS: Recombinant plasmid psil-HBV was constructed and transfected into HepG2.2.15 cells. The transfected cells were cultured in lamivudine-containing medium (0.05 micromol/L) and harvested at 48, 72 and 96 h. The concentration of HBeAg and HBsAg was determined using ELISA. HBV DNA replication was examined by real-time PCR and the level of HBV mRNA was measured by RT-PCR. RESULTS: In HepG2.2.15 cells treated with combination of siRNA and lamivudine, the secretion of HBeAg and HBsAg into the supernatant was found to be inhibited by 91.80% and 82.40% (2.89+/-0.48 vs 11.73+/-0.38, P<0.05; 4.59+/-0.57 vs 16.25+/-0.48, P<0.05) at 96 h, respectively; the number of HBV DNA copies within culture medium was also significantly decreased at 96 h (1.04+/-0.26 vs 8.35+/-0.33, P<0.05). Moreover, mRNA concentration in HepG2.2.15 cells treated with combination of siRNA and lamivudine was obviously lower compared to those treated either with siRNA or lamivudine (19.44+/-0.17 vs 33.27+/-0.21 or 79.9+/-0.13, P<0.05). CONCLUSION: Combination of siRNA and lamivudine is more effective in inhibiting HBV replication as compared to the single use of siRNA or lamivudine in HepG2.2.15 cells.


Assuntos
Antivirais/farmacologia , Vírus da Hepatite B/fisiologia , Lamivudina/farmacologia , RNA Interferente Pequeno/farmacologia , Replicação Viral/efeitos dos fármacos , Antivirais/uso terapêutico , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/virologia , Linhagem Celular Tumoral , Replicação do DNA/efeitos dos fármacos , DNA Viral/metabolismo , Quimioterapia Combinada , Hepatite B/tratamento farmacológico , Antígenos de Superfície da Hepatite B/metabolismo , Antígenos E da Hepatite B/metabolismo , Vírus da Hepatite B/genética , Humanos , Lamivudina/uso terapêutico , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/virologia , RNA Mensageiro/metabolismo , RNA Interferente Pequeno/uso terapêutico , RNA Viral/metabolismo , Transfecção
16.
Jpn J Infect Dis ; 59(1): 42-5, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16495633

RESUMO

The objective of this research was to determine the relationship between YMDD mutations and the genotypes of hepatitis B virus (HBV) during lamivudine treatment. HBV genotypes were determined by nested PCR with 6 pairs of HBV genotype-specific primers (A to F) in serum specimens from 142 hepatitis B patients receiving lamivudine antiviral therapy. YMDD mutations were detected by fluorescent hybridization bioprobe PCR and melting curve assay (FH-PCR-MC). Among 142 serum specimens, 13 samples were genotype B (9.2%), 125 samples were genotype C (88%), 4 samples were genotype D (2.8%), and 80 YMDD mutations were found. The YMDD mutation rates were 69.2 and 54.4% in genotype B and genotype C, respectively. There was no significant difference in the YMDD mutation rate between genotypes B and C. Nine genotype B sera with YMDD mutations were found, including 2 YIDD mutations and 7 YVDD (M + V) mutations. Sixty-eight genotype C sera with YMDD mutations were found, including 34 mutations I (M + I) and 17 mutations V (M + V). There was a significant difference in the YMDD mutation types between genotypes B and C. Our results suggested that the YMDD mutation rate was 56.3% in patients treated with lamivudine for 2-4 years. YIDD was the main mutation type. The YMDD mutation rate showed no significant difference between HBV types B and C (P > 0.05), while the YMDD mutation types showed a significant difference between HBV types B and C in Northern China (chi2 test = 4.6, P < 0.05).


Assuntos
Antivirais/uso terapêutico , Vírus da Hepatite B/genética , Hepatite B/tratamento farmacológico , Hepatite B/virologia , Lamivudina/uso terapêutico , China , Análise Mutacional de DNA , Genes Virais/genética , Genótipo , Humanos , Mutação , Reação em Cadeia da Polimerase/métodos , Inibidores da Transcriptase Reversa/uso terapêutico
17.
Jpn J Infect Dis ; 59(6): 353-7, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17186951

RESUMO

Associations were studied between the polymorphism of northern Han Chinese leukocyte antigen (HLA) alleles and the outcomes of hepatitis B virus (HBV) infection and HBV genotypes. HLA-A, B, and DRB1 alleles in peripheral blood mononuclear cells (PBMCs) were detected by polymerase chain reaction (PCR) with sequence-specific primers. The PBMCs were collected from 61 persons who tested positive for hepatitis B surface antigen (HBsAg) for more than 6 months (Persistent group), 32 persons who tested negative for both HBsAg and HBV DNA but positive for both anti-HBc and anti-HBs (Recovered group), and 40 persons who tested negative for all serologic markers of HBV infection (Uninfected group). HBV genotypes in serum specimens from 56 of 61 patients with persistent HBV infection were determined by nested PCR with 6 pairs of HBV genotype-specific primers (A to F). The frequency of HLA-DRB1*12 was significantly higher in the Persistent group than in the Recovered group (P=0.004). HLA-A*02 was significantly higher in the Recovered group than in the Persistent group (P=0.044). HLA-DRB1*15 was significantly higher in the HBV genotype B group than in the C group (P=0.013). These findings suggested that there were associations not only between HLA polymorphisms and outcomes of HBV infection but also between HLA polymorphisms and the infected HBV genotypes.


Assuntos
Antígenos HLA/genética , Vírus da Hepatite B/classificação , Hepatite B/genética , Hepatite B/fisiopatologia , Polimorfismo Genético , China , Progressão da Doença , Antígenos HLA/sangue , Antígenos HLA/classificação , Antígenos HLA-A/sangue , Antígenos HLA-A/genética , Antígenos HLA-B/sangue , Antígenos HLA-B/genética , Antígenos HLA-DR/sangue , Antígenos HLA-DR/genética , Cadeias HLA-DRB1 , Hepatite B/virologia , Antígenos de Superfície da Hepatite B/sangue , Vírus da Hepatite B/genética , Humanos
18.
Artigo em Inglês | MEDLINE | ID: mdl-16771218

RESUMO

We conducted seroepidemiological studies on antibody prevalence to hepatitis E virus (HEV) in 5,233 sera from 11 countries to ascertain the present state of HEV infection on a global basis. The prevalence of anti-HEV IgG increased with age in these tested countries, but the rate of antibody positivity was over 20% in the 16-30 year-old group in most of the participating countries, except for Japan, the USA, and Spain. Of patients with acute hepatitis of unknown etiology from Nepal, 56% (14/25) were positive for the IgM class of anti-HEV antibody. In addition, HEV RNAs in the serum from 3 Nepali patients who had the IgM antibody were detected by nested PCR and all of the HEV genes isolated belonged to genotype 1. Our results indicate that HEV is spreading worldwide, not only in developing countries, but also in more industrialized countries than previously thought.


Assuntos
Saúde Global , Hepatite E/epidemiologia , Cooperação Internacional , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Ásia/epidemiologia , Bolívia/epidemiologia , Criança , Pré-Escolar , Egito/epidemiologia , Europa (Continente)/epidemiologia , Feminino , Inquéritos Epidemiológicos , Anticorpos Anti-Hepatite/sangue , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Estudos Soroepidemiológicos , Estados Unidos/epidemiologia
19.
Anal Chim Acta ; 916: 77-83, 2016 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-27016441

RESUMO

We present a facile fabrication of layer-by-layer (LbL) microarrays of quantum dots (QDs) and acetylcholinesterase enzyme (AChE). The resulting arrays had several unique properties, such as low cost, high integration and excellent flexibility and time-saving. The presence of organophosphorous pesticides (OPs) can inhibit the AChE activity and thus changes the fluorescent intensity of QDs/AChE microscopic dot arrays. Therefore, the QDs/AChE microscopic dot arrays were used for the sensitive visual detection of OPs. Linear calibration for parathion and paraoxon was obtained in the range of 5-100 µg L(-1) under the optimized conditions with the limit of detection (LOD) of 10 µg L(-1). The arrays have been successfully used for detection of OPs in fruits and water real samples. The new array was validated by comparison with conventional high performance liquid chromatography-mass spectrometry (HPLC-MS).


Assuntos
Enzimas/química , Compostos Organofosforados/análise , Praguicidas/análise , Pontos Quânticos , Limite de Detecção , Espectrofotometria Ultravioleta
20.
Adv Mater ; 28(34): 7397-404, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27309631

RESUMO

An inactive organoplatinum(IV)-substituted polyoxometalate is developed as an efficient and nontoxic prodrug with significant potential for treating human colorectal cancers. Further encapsulation of Pt(IV) -PW11 with DSPE-PEG2000 nanoparticles (NPs) enables targeted delivery and controlled release of inactive prodrug. Such Pt(IV) -PW11 -DSPE-PEG2000 NPs are highly efficient in inhibiting cellular growth of HT29 cells and treating human colorectal cancer in mice, superior to classic cisplatin.


Assuntos
Neoplasias Colorretais , Animais , Antineoplásicos , Linhagem Celular Tumoral , Cisplatino , Sistemas de Liberação de Medicamentos , Humanos , Camundongos , Nanopartículas , Pró-Fármacos , Compostos de Tungstênio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA